NLRP3 and breast cancer: In contrast, treatment with cryptotanshinone reduced LPS-induced BC cell malignant behaviors as well as NLRP3 and inflammatory cytokine expression; however, NLRP3 overexpression reversed the inhibitory effects of cryptotanshinone on LPS-induced BC cell malignant phenotypes and the expression of different proteins.